Cargando…
Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19
BACKGROUND: The emergence and rapid spread of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in thelate 2019 has caused a devastating global pandemic of the severe pneumonia-like disease coronavirus disease 2019 (COVID-19). Although vaccines have been and are being developed, they are...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529228/ https://www.ncbi.nlm.nih.gov/pubmed/34674775 http://dx.doi.org/10.1186/s40360-021-00519-5 |